How Long Vyvanse Stays in Your System

Vyvanse is a brand of lisdexamfetamine. The body turns it into dextroamphetamine [2]. That one fact answers most of what people come here to ask.

A lab screen is not looking for Vyvanse. It looks for amphetamine. So the figure that applies is the amphetamine figure. The federal source for it gives a typical urine window of 2 to 4 days [1].

This page says where that number comes from. It also says what the number is not. If you are here because the clock matters more than the medicine does, start at the last two sections. Our overview of Vyvanse misuse covers the drug itself.

How Long Vyvanse Is Detectable: The Short Answer

Two to four days in urine, typically. That is the amphetamine row, not a Vyvanse row [1].

The source is SAMHSA’s Treatment Improvement Protocol 47, Appendix B. It holds a table called Urine Toxicology Detection Periods for Different Substances. The row reading “amphetamine or methamphetamine” gives 2 to 4 days [1]. This is 2006 federal guidance. It is the table this site uses for every drug, so the figures here match the ones on our other pages.

Vyvanse has no row of its own in that table. No page here will invent one.

What links the two is on the medicine’s own FDA label. The label says lisdexamfetamine is converted to dextroamphetamine and l-lysine. That happens mostly in the blood, through the work of red blood cells, after the capsule is swallowed [2]. The label puts it more bluntly elsewhere. It calls the drug a prodrug of amphetamine, a Schedule II controlled substance [2].

That is the whole chain. Vyvanse becomes dextroamphetamine. Dextroamphetamine is an amphetamine. Amphetamine is what the lab reports.

Urine, Blood, Saliva and Hair Windows

The same appendix holds a second table. It is called Effectiveness of Drug Detection Methods That Use Different Biological Products. Its figures are per specimen, not per drug [1].

Urine is given as 2 to 4 days. Saliva is 12 to 24 hours. Blood is 12 to 24 hours. Sweat is 1 to 4 weeks. Hair is 4 to 6 months [1].

Those are the numbers this site states, because that appendix is the one source it uses for a detection window. A figure made up for one brand is a figure nobody can check.

Read the limits column beside each row. It is more use than the window itself. The table calls blood invasive and costly, and says it finds only current use [1]. It calls saliva very short and easy to contaminate [1]. Hair measures long-term use, but the table calls it costly and slow, with no dose-response relation established [1]. Urine is the common case. The table calls it mature, but says it finds only recent use and needs costly confirmation to be accurate [1].

None of those specimen figures are specific to Vyvanse. They describe what a specimen can do, across drugs. If a page gives you an exact Vyvanse number for hair, ask which federal table it came from.

Vyvanse Half-Life and What That Actually Means

A half-life and a detection window are different things. Mixing them up is the most common error on this topic.

The FDA label reports the half-life of lisdexamfetamine itself. It typically averaged less than one hour in volunteers aged 6 and over [2]. That is the prodrug vanishing. It is not the effect ending. It vanishes because it is being converted.

The half-life that matters next belongs to dextroamphetamine. The label gives roughly 8.6 to 9.5 hours in children aged 6 to 12. In healthy adults it gives 10 to 11.3 hours [2].

A half-life says how long the body takes to clear half of what is in the blood. A window says how long a test can still find a trace above its cutoff. The second is always longer. It also depends on the test, not just the person. Our explainer on how tolerance differs from addiction covers the third thing people confuse with both.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Why the Same Prescription Clears Differently in Different People

Because the window was never a fact about the drug alone.

The appendix says so, and its list is worth reading in full. How long a drug or its traces can be found in urine depends on many things at once. The drug’s own chemistry, such as its half-life. The speed at which a body breaks it down, and how it leaves. The amount taken, how it was taken, how often, and for how long. The sensitivity of the assay. And the person’s own health, exercise, diet, weight, gender and fluid intake, all of which change how fast things are excreted [1].

Two results follow, and both are in the source. The more taken, and the longer the habit, the more likely a trace is found [1]. And drugs build up with steady use, even though each leaves at its own rate [1].

One more line matters here. The appendix notes that most drugs can be found for roughly 2 to 4 days. It adds that it may be hard to find anything in someone who stopped several days before a screen [1]. The appendix’s very next sentence is the one that closes the loop: an accurate profile of a client’s substance use over more than a few days requires both urine test results and a good retrospective history [1]. That is a note about a test’s limits, written for clinicians weighing a result. It is not a plan, and this page does not offer one.

False Positives and What Else Can Trigger Them

A first positive screen is not the end of the process. With amphetamines, that matters more than most.

The appendix names the problem. Cross-reactivity is a bigger worry for amphetamines, benzodiazepines and opioids than for cocaine or marijuana [1]. It then gives a plain example. Phenylpropanolamine or ephedrine in cold remedies can cause false positives for amphetamines [1].

This is why federal testing runs in two stages. The Department of Transportation rule at 49 CFR 40.85 sets the cutoffs a lab must use. It gives separate figures for the first test and the confirming test, for amphetamine and methamphetamine among others [3]. A first result is a signal. The confirming step is what a lab stands behind. The appendix calls gas chromatography with mass spectrometry the gold standard, while noting the cost [1].

If you take a prescribed stimulant and a result surprises you, raise it with two people. The prescriber who wrote it. And the medical review officer attached to the program. Our guide to the signs that use has become a problem covers a different question, further down.

Detection Windows Are Not a Safety Measure

This section exists because the search term and the real problem are often not the same thing.

A window tells you what a test can find. It tells you nothing else. Not whether a person is well. Not whether a prescription is working. Not whether use has drifted somewhere it should not be. The appendix is blunt about this. Findings cannot tell you when a drug was taken, how much, how it was taken, or how impaired anyone was [1].

So a clear result settles one narrow question and leaves every medical one open. Someone who stops for a few days to reach that result has changed nothing about the pattern underneath. The pattern is what eventually costs them something.

This page publishes no timing advice, no dilution methods and no other trick aimed at a result. That kind of help runs out by the morning of the appointment.

The FDA label lists what misuse of this drug may cause. The list is not short. A faster heart rate, faster breathing or higher blood pressure. Sweating. Wide pupils. Restlessness and trouble sleeping. Less appetite. Poor coordination, tremors and flushed skin. Vomiting and belly pain [2].

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

When Frequent Vyvanse Use Has Become Dependence

The label is the clearest description we have. It also splits three things that ordinary speech runs together.

The drug may cause tolerance. The label defines that as a smaller response after repeated use, so more is needed for the effect once had with less [2]. It may also cause physical dependence. That is the body adapting, and it shows up as withdrawal signs after a sudden stop or a sharp cut [2]. Neither is addiction on its own.

Addiction, in the label’s words, is a cluster of behaviors, thoughts and bodily states. It may include a strong wish to take the drug. It may include trouble controlling use, carrying on despite harm, and putting the drug ahead of other duties [2]. The label carries a boxed warning on abuse, misuse and addiction. It records a high potential for abuse and misuse, which can lead to a substance use disorder [2]. MedlinePlus says the same thing in one line for patients. Lisdexamfetamine can be habit-forming [4].

Note how the label defines the state rather than the conduct. Physical dependence is a state that develops as a result of physiological adaptation in response to repeated drug use [2]. The label also names what withdrawal looks like after prolonged use of a CNS stimulant: dysphoric mood, depression, fatigue, vivid and unpleasant dreams, insomnia or hypersomnia, increased appetite, and psychomotor retardation or agitation [2].

So physical dependence is a physiological state and not a verdict on anybody’s behavior; the label keeps it separate from addiction, which it defines by behavior [2]. It is also not a reason to stop on your own. What to do about a prescription you no longer want is a conversation with the prescriber who wrote it. Our page on withdrawal symptoms describes what stopping can involve across drug classes.

Getting Help With Vyvanse Use

Say the honest answer to “why am I reading this” is that use has moved past the prescription. Then the next step is an assessment, not a decision.

An assessment is a talk with a clinician. They take the history, including what else is being used. Then they recommend a level of care. The Recovery Village Cherry Hill at Cooper publishes medical detox, inpatient treatment, partial hospitalization programming, intensive outpatient programming, outpatient programming and aftercare planning on its own page [6]. Which one fits is not something an article can settle. Nobody should arrive having already ruled options out.

Two practical points. First, medical detox and outpatient care are two ends of a ladder, not rivals. Our levels of care explainer sets out the five main levels of treatment, and our page on inpatient rehab covers what a stay asks of a person. Second, check coverage before the call rather than after it. Start with our guide to whether insurance covers rehab and our page on what rehab costs, which gives our own published ranges. Our page on how admission works sets out the order of events, and our list of our treatment centers shows where our campuses are.

If this is about someone else, the same holds with one change. Bring what you have seen, not what you have concluded.

This is a common worry, not a rare one. NIDA reports an overall increase in prescription drug misuse over the past two decades, reflected in treatment admissions for prescription drug use disorders and in overdose deaths involving prescription drugs, both of which initially rose significantly before holding steady through 2020 [5].

Frequently Asked Questions

Sources

1. Center for Substance Abuse Treatment. (2006). Substance Abuse: Clinical Issues in Intensive Outpatient Treatment (TIP 47), Appendix B: Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64092/
2. U.S. National Library of Medicine. (2026). Lisdexamfetamine Dimesylate Capsules — Full Prescribing Information: Clinical Pharmacology, Drug Abuse and Dependence. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f2dd6ee-3363-c87c-9693-ed838942556c
3. Legal Information Institute. 49 CFR 40.85 — What are the cutoff concentrations for urine drug tests?. Cornell Law School. https://www.law.cornell.edu/cfr/text/49/40.85
4. U.S. National Library of Medicine. Lisdexamfetamine. MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a607047.html
5. National Institute on Drug Abuse. Misuse of Prescription Drugs Research Report: Overview. National Institutes of Health. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/overview
6. The Recovery Village. The Recovery Village Cherry Hill at Cooper — Levels of Care. Advanced Recovery Systems. https://www.therecoveryvillage.com/locations/cherry-hill/

This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.

Author

Kevin Wandler, MD

Chief Medical Officer, The Recovery Village